Neuberger Berman Group LLC Acadia Pharmaceuticals Inc Transaction History

Neuberger Berman Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$25.02 - $54.99 $11.8 Million - $25.9 Million	-470,900 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$41.04 - $56.79 $3.81 Million - $5.27 Million	92,800 Added 24.54%	470,900 $25.2 Million
Q3 2020 Nov 12, 2020	BUY	$36.42 - $57.0 $5.83 Million - $9.12 Million	160,000 Added 73.36%	378,100 $0
Q2 2020 Aug 13, 2020	BUY	$39.26 - $52.73 $6.48 Million - $8.7 Million	165,000 Added 310.73%	218,100 $10.6 Million
Q1 2020 May 14, 2020	BUY	$31.65 - $46.87 $411,450 - $609,310	13,000 Added 32.42%	53,100 $0
Q4 2019 Feb 12, 2020	BUY	$36.21 - $51.4 $496,077 - $704,180	13,700 Added 51.89%	40,100 $1.72 Million
Q3 2019 Nov 13, 2019	BUY	$22.22 - $44.01 $62,216 - $123,228	2,800 Added 11.86%	26,400 $950,000
Q2 2019 Aug 13, 2019	BUY	$23.32 - $28.12 $247,192 - $298,072	10,600 Added 81.54%	23,600 $631,000
Q1 2019 May 13, 2019	BUY	$16.17 - $27.38 $210,210 - $355,940	13,000 New	13,000 $349,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.